Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study

Abstract

OBJECTIVES: The aim of the study was to assess weight changes associated with certain atypical (AAP) and typical (TAP) antipsychotic drugs in patients with early-onset schizophrenia and other related psychotic disorders.

Keywords

• Schizophrenia
• antipsychotics
• weight gain
• adolescence
• 2nd-generation antipsychotics
• onset schizophrenia
• drug-treatment
• double-blind
• children
• risperidone
• olanzapine
• tolerability
• obesity
• medications